Skip to content
← Back to this collection

PUBLICATIONS · 17892918

Multi-institution prospective trial of reduced-dose craniospinal irradiation (23.4 Gy) followed by conformal posterior fossa (36 Gy) and primary site irradiation (55.8 Gy) and dose-intensive chemotherapy for average-risk medulloblastoma.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Int J Radiat Oncol Biol Phys
Publication date
2008 Mar 1
First author
Merchant TE

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships

    Authors and identifiers

    1. name
      Merchant TE
      type
      Author
    2. name
      Kun LE
      type
      Author
    3. name
      Krasin MJ
      type
      Author
    4. name
      Wallace D
      type
      Author
    5. name
      Chintagumpala MM
      type
      Author
    6. name
      Woo SY
      type
      Author
    7. name
      Ashley DM
      type
      Author
    8. name
      Sexton M
      type
      Author
    9. name
      Kellie SJ
      type
      Author
    10. name
      Ahern V
      type
      Author
    11. name
      Gajjar A
      type
      Author
    Complete bibliographic record and source provenance
    authors
    1. name
      Merchant TE
      type
      Author
    2. name
      Kun LE
      type
      Author
    3. name
      Krasin MJ
      type
      Author
    4. name
      Wallace D
      type
      Author
    5. name
      Chintagumpala MM
      type
      Author
    6. name
      Woo SY
      type
      Author
    7. name
      Ashley DM
      type
      Author
    8. name
      Sexton M
      type
      Author
    9. name
      Kellie SJ
      type
      Author
    10. name
      Ahern V
      type
      Author
    11. name
      Gajjar A
      type
      Author
    bibliography ids
    1. nci-bib-33b2c1793d154efac4ad86a4
    book metadata
    content sha256
    c42990924521a8b1a9b04c5b4a856590a785b561b75c30febcf21a36dd5fcf1d
    document type
    citation
    dois
    1. 10.1016/j.ijrobp.2007.07.2342
    electronic publication date
    display
    2007 Sep 24
    precision
    day
    year
    2007
    evidence scope
    bibliographic_metadata_only
    id
    pubmed:17892918
    immutable id
    pubmed:17892918@c42990924521a8b1a9b04c5b4a856590a785b561b75c30febcf21a36dd5fcf1d
    journal
    abbreviation
    Int J Radiat Oncol Biol Phys
    issn electronic
    1879-355X
    issn print
    0360-3016
    issue
    3
    name
    International journal of radiation oncology, biology, physics
    nlm unique id
    7603616
    pages
    782-7
    volume
    70
    languages
    1. eng
    notices
    absence is not clearance
    true
    has correction metadata
    false
    has expression of concern metadata
    false
    has retraction in link
    false
    pubmed marks article retracted
    false
    pubmed marks retraction notice
    false
    relationships
      outcomes validated
      false
      pmid
      17892918
      provenance
      batch id
      89a0f2206e11ca092d02
      provider
      NCBI PubMed ESummary
      record sha256
      3a6d705314e4a8e61f98ed0f8e7bf2f67f33fcaa1929fa19596b89ed8c6bc0a0
      response sha256
      7b1c355120884a7a596bcf7b4a243dc12308b7f7f0914c3fc71b0c8e8d79c708
      retrieved at
      2026-09-09T23:46:16.784581+00:00
      publication date
      display
      2008 Mar 1
      precision
      day
      year
      2008
      publication types
      1. Clinical Trial
      2. Journal Article
      3. Multicenter Study
      4. Research Support, N.I.H., Extramural
      5. Research Support, Non-U.S. Gov't
      record status
      PubMed - indexed for MEDLINE
      schema version
      1.0
      source url
      https://pubmed.ncbi.nlm.nih.gov/17892918/
      title
      Multi-institution prospective trial of reduced-dose craniospinal irradiation (23.4 Gy) followed by conformal posterior fossa (36 Gy) and primary site irradiation (55.8 Gy) and dose-intensive chemotherapy for average-risk medulloblastoma.

      Preserved source evidence · Not medical advice